Literature DB >> 19186197

Susceptibility of the Aotus nancymaae owl monkey to eastern equine encephalitis.

Benjamin J Espinosa1, Scott C Weaver, Slobodan Paessler, Douglas Brining, Milagros Salazar, Tadeusz Kochel.   

Abstract

Eastern equine encephalitis virus (EEEV) is an arthropod-borne virus associated with life-threatening encephalitis in humans, equines, birds and many other domestic animals. To investigate the suitability of the Aotus nancymaae New World owl monkey as a viable animal model for EEE candidate vaccine testing we used clinical presentation, serology, viral isolation and PCR to evaluate pathogenesis and immunity in infected animals. Monkeys were inoculated subcutaneously (SQ) or intranasally (IN) with 10(4)pfu of virulent EEEV and were initially followed for 45 days. While none of the animals displayed clinical signs of disease, all of the SC inoculated animals (n=6) manifested a viremia averaging 3.2 days (+/-0.8 days). Likewise, serologic responses (IgM, IgG and PRNT) were observed in all SC infected animals. Interestingly, none of the IN inoculated animals (n=6) became viremic or mounted an antibody response and no pathological abnormalities were observed in two animals that were necropsied on day 6 post-infection (p.i.) from each group. To determine if the antibodies produced by the SC inoculated animals were protective against homologous challenge, three animals from the SC group were serologically evaluated on day 253 p.i. and were administered an inoculum identical to initial challenge on day 270 p.i. A positive control group of four naïve animals was also infected as before. All of the naïve positive control animals manifested a similar viremia as observed initially, averaging 2.75 days (+/-0.5 days) while none of the previously challenged animals became viremic. On days 45 and 253 p.i. geometric mean PRNT titers in the SC group were 453 and 101, respectively. This study demonstrates that the Aotus nancymaae can be reproducibly infected with EEE virus and can serve as a suitable model for infection and immunogenicity for the evaluation of candidate vaccines against EEEV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19186197      PMCID: PMC3586983          DOI: 10.1016/j.vaccine.2009.01.029

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Antibody response of sandhill and whooping cranes to an eastern equine encephalitis virus vaccine.

Authors:  G G Clark; F J Dein; C L Crabbs; J W Carpenter; D M Watts
Journal:  J Wildl Dis       Date:  1987-10       Impact factor: 1.535

2.  Severe encephalitis in cynomolgus macaques exposed to aerosolized Eastern equine encephalitis virus.

Authors:  Douglas S Reed; Matthew G Lackemeyer; Nicole L Garza; Sarah Norris; Scott Gamble; Lawrence J Sullivan; Cathleen M Lind; Jo Lynne Raymond
Journal:  J Infect Dis       Date:  2007-06-21       Impact factor: 5.226

3.  An inactivated eastern equine encephalomyelitis vaccine propagated in chick-embryo cell culture. I. Production and testing.

Authors:  L F Maire; R W McKinney; F E Cole
Journal:  Am J Trop Med Hyg       Date:  1970-01       Impact factor: 2.345

4.  Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.

Authors:  Donald L Fine; Brian A Roberts; Max L Teehee; Sara J Terpening; Cindy L H Kelly; Janae L Raetz; Dale C Baker; Ann M Powers; Richard A Bowen
Journal:  Vaccine       Date:  2006-10-27       Impact factor: 3.641

5.  Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization.

Authors:  D M Morens; S B Halstead; P M Repik; R Putvatana; N Raybourne
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

6.  Response to and efficacy of vaccination against eastern equine encephalomyelitis virus in emus.

Authors:  L A Tengelsen; R A Bowen; M A Royals; G L Campbell; N Komar; R B Craven
Journal:  J Am Vet Med Assoc       Date:  2001-05-01       Impact factor: 1.936

7.  An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

Authors:  B L Innis; A Nisalak; S Nimmannitya; S Kusalerdchariya; V Chongswasdi; S Suntayakorn; P Puttisri; C H Hoke
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

8.  The hamster as an animal model for eastern equine encephalitis--and its use in studies of virus entrance into the brain.

Authors:  Slobodan Paessler; Patricia Aguilar; Michael Anishchenko; Hui-Qun Wang; Judith Aronson; Gerald Campbell; Ann-Sophie Cararra; Scott C Weaver
Journal:  J Infect Dis       Date:  2004-05-06       Impact factor: 5.226

9.  Evaluation of vero cell lysate antigen for the ELISA of flaviviruses.

Authors:  M Z Ansari; R E Shope; S Malik
Journal:  J Clin Lab Anal       Date:  1993       Impact factor: 2.352

Review 10.  Monkey B virus (Cercopithecine herpesvirus 1).

Authors:  David Elmore; Richard Eberle
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

View more
  1 in total

1.  Eastern equine encephalitis virus in mice II: pathogenesis is dependent on route of exposure.

Authors:  Shelley P Honnold; Eric C Mossel; Russell R Bakken; Cathleen M Lind; Jeffrey W Cohen; Lori T Eccleston; Kevin B Spurgers; Rebecca Erwin-Cohen; Pamela J Glass; Radha K Maheshwari
Journal:  Virol J       Date:  2015-09-30       Impact factor: 4.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.